Covidien plc Takes A $180 Million Legal Charge In Third Quarter

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Medical device maker Covidien Plc said it recorded a pre-tax charge of about $180 million for the third quarter, related to litigation against some manufacturers of pelvic mesh products.

The company’s two units supplied pelvic mesh products to one of the manufacturers named in a lawsuit. Covidien said it was indemnifying the manufacturer on certain claims. (1.usa.gov/1kcXcYk)

The manufacturers have alleged injuries to users resulting from the implantation of products supplied by Covidien.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC